Aprotinin significantly reduces red blood cell transfusion requirements in patients undergoing orthotopic liver transplantation
Kufner, R.P.; Ereth, M.H.; Krom, R.A.F.; Findlay, J.Y.; Rettke, S.R.
Anesthesiology 89(3A): A267
1998
ISSN/ISBN: 0003-3022 Accession: 030161468
Full Text Article emailed within 1 workday: $29.90
Related References
Merle, J.C.; Cherqui, D.; Lauzet, J.Y.; Malassagne, B.; Duvoux, C.; Fagniez, P.L.; Duvaldestin, P. 1997: Aprotinin significantly reduces blood transfusion requirements in liver transplantation for severe cirrhosis A double-blind randomized controlled trial Anesthesiology 87(3 Suppl): A83Findlay, J.Y.; Rettke, S.R.; Ereth, M.H.; Plevak, D.J.; Krom, R.A.; Kufner, R.P. 2001: Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 7(9): 802-807
Mallett, S.V.; Cox, D.; Burroughs, A.K.; Rolles, K. 1990: Aprotinin and reduction of blood loss and transfusion requirements in orthotopic liver transplantation Lancet 336(8719): 886-887
Molenaar, I.Q.; Porte, R.J. 2004: The Impact of Aprotinin on Transfusion Requirements in Orthotopic Liver Transplantation Transfusion Alternatives in Transfusion Medicine 6(s 4): 34-38
Rentoul, T.M.; Harrison, V.L.; Shun, A. 2003: The effect of aprotinin on transfusion requirements in pediatric orthotopic liver transplantation Pediatric Transplantation 7(2): 142-148
Patrassi, G.M.; Viero, M.; Sartori, M.T.; De Silvestro, G.; Rossaro, L.; Burra, P.; Nolli, M.L.; Piccinni, P.; Bassi, N. 1994: Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation Transfusion 34(6): 507-511
Liu, C.-M.; Chen, J.; Wang, X.-H. 2008: Requirements for transfusion and postoperative outcomes in orthotopic liver transplantation: a meta-analysis on aprotinin World Journal of Gastroenterology 14(9): 1425-1429
Boylan, J.F.; Klinck, J.R.; Sandler, A.N.; Arellano, R.; Greig, P.D.; Nierenberg, H.; Roger, S.L.; Glynn, M.F.X.; Phil, D. 1996: Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation Anesthesiology (Philadelphia) 85(5): 1043-1048
Boylan, J.F.; Klinck, J.R.; Sandler, A.N.; Arellano, R.; Greig, P.D.; Nierenberg, H.; Roger, S.L.; Glynn, M.F. 1996: Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation Anesthesiology 85(5): 1043-8; discussion 30A-31A
Porte, R.J.; Molenaar, I.Q.; Begliomini, B.; Groenland, T.H.; Januszkiewicz, A.; Lindgren, L.; Palareti, G.; Hermans, J.; Terpstra, O.T. 2000: Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group Lancet 355(9212): 1303-1309
Porte, R.J.; Quintus Molenaar, I.; Begliomini, B.; Groenland, T.H.N.; Januszkiewicz, A.; Lindgren, L.; Palareti, G.; Hermans, J.; Terpstra, O.T. 2000: Aprotinin and transfusion requirements in orthotopic liver transplantation : a multicentre randomised double-blind study Lancet (British Edition) 355(9212): 1303-1309
Ickx, B.E.; van der Linden, P.J.; Melot, C.; Wijns, W.; de Pauw, L.; Vandestadt, J.; Hut, F.; Pradier, O. 2006: Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation Transfusion 46(4): 595-605
Uzuni, A.; El-Bashir, J.; Galusca, D.; Yeddula, S.; Nagai, S.; Yoshida, A.; Abouljoud, M.S.; Otrock, Z.K. 2022: Transfusion requirements and alloimmunization to red blood cell antigens in orthotopic liver transplantation Vox Sanguinis 117(3): 408-414
Lanigan, M.; Siers, D.; Wilkey, A.; Barakat, A.; Shaffer, A.; John, R.; Knoper, R.; Huddleston, S.; Kaizer, A.; Perry, T.E. 2022: The use of a Viscoelastic-Based Transfusion Algorithm Significantly Reduces Non-red Blood Cell Transfusion in Patients Undergoing Left Ventricular Assist Device Placement or Heart Transplantation: a Single-Center Observational Study Journal of Cardiothoracic and Vascular Anesthesia 36(8 Part B): 3038-3046
Ickx, B.; Pradier, O.; De Groote, F.; Hendrice, C.; Gelin, M.; Van De Stadt, T.J.; Capel, P. 1993: Does aprotinin really reduces blood loss during orthotopic liver transplantation? Hepatology 18(3): 740
Murkin, J.M.; Shannon, N.; Guiraudon, G.; Mckenzie, F.N.; Menkis, A.H.; Novick, R.J. 1992: High dose aprotinin significantly decreases blood loss and transfusion requirements in asa treated surgical patients undergoing cardiopulmonary bypass Anesthesiology 77(3A): A155
Bechstein, W.O.; Riess, H.; Neuhaus, P.; Himmelreich, G.; Steffen, R.; Slama, K.J.; Rossaint, R.; Blumhardt, G. 1991: The effect of aprotinin on blood product requirements during orthotopic liver transplantation Clinical Transplantation 5(6): 422-426
Lassale, B.; Rathelot, P.; Angelini, B.; Bongrand, M.C.; Timon-David, P. 1996: Aprotinin in orthotopic liver transplantation (OLT): Clinical and economical interest in blood requirements Journal de Pharmacie Clinique 15(3): 187-191
Llamas, P.; Cabrera, R.; Gómez-Arnau, J.; Fernández, M.N. 1998: Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin Haematologica 83(4): 338-346
Smith, O.; Hazlehurst, G.; Brozovic, B.; Rolles, K.; Burroughs, A.; Mallett, S.; Dawson, K.; Mehta, A. 1993: Impact of aprotinin on blood transfusion requirements in liver transplantation Transfusion Medicine 3(2): 97-102